Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Jan 25 | OTLK Outlook Therapeutics | Warrants Common Stock | Grant | Acquire A | Yes | No | 2.26 | 3,458,571 | 7.82 mm | 3,458,571 |
17 Jan 25 | OTLK Outlook Therapeutics | Warrants Common Stock | Grant | Acquire A | Yes | No | 2.26 | 3,458,571 | 7.82 mm | 3,458,571 |
17 Jan 25 | OTLK Outlook Therapeutics | Warrants Common Stock | Option exercise | Dispose M | Yes | No | 2.51 | 3,458,571 | 8.68 mm | 0 |
17 Jan 25 | OTLK Outlook Therapeutics | Warrants Common Stock | Grant | Acquire A | Yes | No | 2.51 | 3,458,571 | 8.68 mm | 3,458,571 |
17 Jan 25 | OTLK Outlook Therapeutics | Warrants Common Stock | Sale back to company | Dispose D | Yes | No | 7.7 | 3,458,571 | 26.63 mm | 0 |
18 Mar 24 | OTLK Outlook Therapeutics | Common Stock | Grant | Acquire A | Yes | No | 0 | 2,305,714 | 0.00 | 5,808,074 |
18 Mar 24 | OTLK Outlook Therapeutics | Warrants Common Stock | Grant | Acquire A | Yes | No | 7.7 | 3,458,571 | 26.63 mm | 3,458,571 |